SEATTLE, Oct. 25, 2018
SEATTLE, Oct. 25, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2018 financial results on Thursday, November 1, 2018, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update at 4:30 p.m. ET (1:30 p.m. PT). Access to the event can be obtained as follows:
Thursday, November 1, 2018
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m. CET
+1 334-323-0522 (international)
To access the live audio webcast or the subsequent archived recording, visit CTI BioPharma's website, www.ctibiopharma.com. Webcast and telephone replays of the conference call will be available at approximately two hours after completion of the call. Callers can access the replay by dialing 1-888-203-1112 (domestic) or +1 719-457-0820 (international). The access code for the replay is 4559931. The telephone replay will be available until Thursday, November 8, 2018.
About CTI BioPharma
CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The CTI BioPharma lead product candidate, pacritinib, is being developed for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington.
CTI BioPharma Investor Contacts:
Julia Balanova (investors)
+1 646 378 2936
Rich Allan (media)
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-report-third-quarter-2018-financial-results-on-november-1-2018-300732337.html
SOURCE CTI BioPharma Corp.